Take-aways from a discussion on the management of cold agglutinin disease, with expert insight on navigating the healthcare system to optimize patient care.

I’m going to throw this open. I’ll start with Dr Jeremy Gleeson, but then I want to bring our clinical folks in. What do you think are the pain points in the management of cold agglutinin disease?

DEAR DR. ROACH: What are the symptoms for cold agglutinin disease, and how is it diagnosed? — P.W. ANSWER: Cold agglutinin disease is a specific type of anemia where antibodies attack and ...

The regimen used to treat chronic cold agglutinin disease in several case studies [4,5,6,7,8,9] and in 1 small trial was 375 mg/m 2 weekly for 4 doses. References Medscape Pharmacists. 2002;3(2 ...

Cold agglutinin disease (CAD), a rare hemolytic anemia, is mediated by auto IgM antibodies that generally have a thermal amplitude below core body temperature.

ANSWER: Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person’s own red blood cells. Unlike the usual type of autoimmune hemolytic ( “hemolytic” means ...

Sanofi Drug for Rare Blood Disease Is Heading to Recordati for $825M Recordati is acquiring Sanofi’s Enjaymo, the only approved drug for the rare blood disorder cold agglutinin disease.

FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease. News release. February 4, 2022.

FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease. [press release]. Paris, France: Sanofi; November 13, 2020.

Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person’s own red blood cells. Unlike the usual type of autoimmune hemolytic (“hemolytic” means ...

Q: What are the symptoms for cold agglutinin disease, and how is it diagnosed? – P.W. A: Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person’s own ...

Dear P.W.: Cold agglutinin disease is a specific type of anemia where antibodies attack and destroy a person’s own red blood cells. Unlike the usual type of autoimmune hemolytic (”hemolytic ...